Join the club for FREE to access the whole archive and other member benefits.

Antonio Regalado

Biomedicine Editor at MIT Technology Review

Antonio Regalado is the senior editor for biomedicine for MIT Technology Review. He looks for stories about how technology is changing medicine and biomedical research. Before joining MIT Technology Review in July 2011, he lived in São Paulo, Brazil, where he wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, Antonio was the science reporter at the Wall Street Journal and later a foreign correspondent.

Visit website: https://www.technologyreview.com/author/antonio-regalado/

 antonioregalado

 antonioregalado

See also: Publisher MIT Technology Review - Magazine providing insightful looks into technology trends of the future

Details last updated 08-Feb-2019

Articles written by Antonio Regalado

The quest to rebuild the human brain

The quest to rebuild the human brain

MIT Technology Review - 16-Aug-2024

A groundbreaking approach to extend life through brain tissue renewal

Viral video sparks debate on head transplants for immortality

Viral video sparks debate on head transplants for immortality

MIT Technology Review - 23-May-2024

Experts discuss on the ethics and feasibility of body transplants in the near future

A new gene therapy treatment has helped deaf children hear for the first time

A new gene therapy treatment has helped deaf children hear for the first time

MIT Technology Review - 27-Oct-2023

Treatment delivers a working copy of a missing gene to the inner ear

The quest for synthetic embryos: pioneering the future of regenerative medicine

The quest for synthetic embryos: pioneering the future of regenerative medicine

MIT Technology Review - 04-Aug-2022

Stem-cell science reshaping transplants and longevity

Hevolution Foundation to spend $1 billion annually on the biology of aging

Hevolution Foundation to spend $1 billion annually on the biology of aging

MIT Technology Review - 07-Jun-2022

Considering funding a $100 million age reversal X Prize and the TAME(metformin) trial

Stealthy Harvard startup wants to reverse aging

Stealthy Harvard startup wants to reverse aging

MIT Technology Review - 09-May-2018

Rejuvenate Bio is cofounded by George Church of Harvard Medical School. Will make animals “young...

One-way trip to a digital afterlife: Nectone preserves your brain for the future

One-way trip to a digital afterlife: Nectone preserves your brain for the future

MIT Technology Review - 13-Mar-2018

The startup company raised $1M for its service, but science and ethics remain uncertain

A massive study of family trees finds no gene for longevity

A massive study of family trees finds no gene for longevity

MIT Technology Review - 01-Mar-2018

Birth and death dates of more than 86 million people compared. Studied family trees over the las...

Is This the Anti-Aging Pill We’ve All Been Waiting For?

Is This the Anti-Aging Pill We’ve All Been Waiting For?

MIT Technology Review - 28-Mar-2017

Novartis sought to see whether giving low doses of everolimus to people over 65 increased their r...